Search Results - "Mohamed, Benlazar"

Adults Myelodysplastic Syndromes in Algeria: A Study by the Algerian MDS Group by Bekadja, Mohamed Amine, Fenaux, Pierre, Akrouf, Sabrina, Ahmed-Nacer, Redhouane, Hamladji, Rose-marie, Bouchakour, Amina, Taoussi, Souad, Abad, Mohand Tahar, Bradai, Mohamed, Benzineb, Brahim, Mesli, Naima, Cheritti, M, Zouaoui, Z, Benlazar, Mohamed, Bougherira, Soraya, Grifi, Fatiha, Ait-Ali, Hocine, Allouda, Malika, Djillali, Malika, Djouadi, Khadija, Kherbache, Fatima, Hamdi, Selma, Hamouda, Hakim, Boumeida, Imene, Belhani, Meriem, Boudjerra, Nadia, Kaci, Fatima Zohra, Osmani, Soufi, Yafour, Nabil, Barkat, Soumia, Soltani, Fatma, Nacib, Razika, Saidi, Mahdia, Touati, Laid, Lakhdari, Noureddine, Zouani, Samira, Touhami, Hadj, Saidi, Djamel, Cherif Louazani, Lamia, Ramaoun, Mohamed, Akkal, Cherifa, Mehalhal, Nemra, Krim, Amina, Sidimansour, Noureddine, Ouchenane, Zohra, Zidani, Nadia, Nekkal, Salim, Barkat, Samia, Ouarlent, Y, Aberkane, Mohamed, Belakehal, Salah Eddine, Bachiri, Aissa, Baghdad, Samir

“…Introduction: Myelodysplastic syndromes (MDS) are a group of haematological disorders, whose diagnosis is based mainly on cytological studies of blood and…”
Get full text

CML-216 Hypereosinophilia Syndrome With FIP1L1-PDGFRA Transcript Revealed by Cardiac Involvement by Nadjat, Siali, Mohamed, Benlazar

Get full text

CML-337 Therapeutic Results of Second-Generation TKIs in a CML Multicentric Study in the West Region of Algeria by Nadjat, Siali, Mohamed, Benlazar

Get full text

Poster: CML-337 Therapeutic Results of Second-Generation TKIs in a CML Multicentric Study in the West Region of Algeria by Nadjat, Siali, Mohamed, Benlazar

Get full text

PB2015: DIAGNOSIS, CLASSIFICATION AND STRATIFICATION OF MYELODYSPLASTIC SYNDROMES IN ALGERIA by Moussa, Yamina Bouchakour, Taoussi, Souad, Tayeb, Abad Mohand, Mohamed, Bradai, Akhrouf, Sabrina, Redhouane, Ahmed Nacer, Hamladji, Rose Marie, Boulaziz, Nassima, Ali, Hocine Ait, Malika, Allouda, Benzineb, Brahim, Mesli, Naima, El Amine, Benlazar Sidi Mohamed, Zouaoui, Zahia, Kherbache, Farida, Selma, Hamdi, Hamouda, Hakim, Djillali, Malika, Khadidja, Djouadi, Touati, Laid, Nordine, Lakhdari, Nemra, Mhalhal, Samir, Baghdad, Belakehal, Salah Eddine

Get full text

Global Access to Multiple Myeloma Medications (GLAMM-2 Study): Access and Barriers to Chemoimmunotherapies and Transplant by Mammadzadeh, Aytaj, Shatnawi, Yara, Atallah, Rawan, Mohamed, Benlazar, Desai, Nihar, Hashmi, Shahrukh K, Xavier Carneiro, Thiago, Shaikh, Hira, Strouse, Christopher, Popat, Rakesh, Mahmoudjafari, Zahra, Mushtaq, Muhammad Umair, Abdallah, Al-Ola, Ahmed, Nausheen

“…Introduction Multiple myeloma (MM) is a clonal plasma cell malignancy and is the second most common type of hematologic cancer worldwide. Treatment options for…”
Get full text

The GLAMM1 Study - Global Access to Myeloma Medications: Potential Barriers to Chimeric Antigen Receptors (CART) and T-Cell-Engaging Bispecific Antibodies (TCE) Globally by Atallah, Rawan, Shatnawi, Yara, Mammadzadeh, Aytaj, Hashmi, Shahrukh K, Rana, Shabeeha K, Mushtaq, Muhammad Umair, Mohamed, Benlazar, Desai, Nihar, Xavier Carneiro, Thiago, Popat, Rakesh, McGuirk, Joseph P, Atrash, Shebli, Mahmoudjafari, Zahra, Abdallah, Al-Ola, Ahmed, Nausheen

“…Introduction: Novel B cell maturation antigen (BCMA) directed therapies including chimeric antigen receptor- T (CART) such as idecabtagene vicleucel (ide-cel)…”
Get full text

The GLAMM1 Study - Global Access to Myeloma Medications: Potential Barriers to Chimeric Antigen Receptors (CART) and T-Cell-Engaging Bispecific Antibodies (TCE) Globally by Atallah, Rawan, Shatnawi, Yara, Mammadzadeh, Aytaj, Hashmi, Shahrukh K, Shabeeha, Rana, Mushtaq, Muhammad Umair, Mohamed, Benlazar, Desai, Nihar, Carneiro, Thiago Xavier, Popat, Rakesh, McGuirk, Joseph P, Atrash, Shebli, Mahmoudjafari, Zahra, Logan, Emerson, Abdallah, Al-Ola, Ahmed, Nausheen

“…Access to Novel B cell maturation antigen (BCMA) directed therapies including chimeric antigen receptor- T (CART) appears to be a major challenge worldwide…”
Get full text

Outcome of Frontline Treatment with Generic Imatinib in Adult Patients with Chronic Myeloid Leukemia in Algerian Population: A First Multicenter Study by Entasoltan, Badra, Bekadja, Mohamed Amine, Bouhass, Rachid Amar, Taibi, Karima, Touhami, Hadj, Mehalhal, Nemra, Benlazar, Mohamed, Zouaoui, Zahia, Benzineb, Brahim, Mesli, Naima, Talbi, Mustapha, Yachekour, Toufik, Bachiri, Aissa, Nachi, Mourad

“…▪ Introduction: In a developing country like Algeria, such expensive therapy is not available. Alternative approaches are needed to help these adult. In…”
Get full text

Epidemiological, Clinical, and Biological Characterization of Newly Diagnosed Acute Myeloid Leukemia in Algeria. Report on Behalf of the Algerian Acute Leukemia Study Group by Med Amine, Bekadja, Krim, Amina, Bouhass, Rachid Amar, Rekab, Malika, bouchakor Moussa, Yamina, Taoussi, Souad, Abad, Mohand Tayed, Bradai, Mohamed, Graine, Mohamed, AIT ALI, Hocine, Bouras, Imene, Hamdi, Selma, Ahmed Nacer, Redhouane, Akhrouf, Sabrina, Hamladji, Rose-Marie, Berkouk, Yasmina, Boudjerra, Nadia, Belhani, Meriem, Zouani, Samira, Saidi, Djamel, Touhami, Hadj, Boughrira, Soraya, Grifi, Fatiha, Merrouche, Malika, Saidi, Mahdia, Benzineb, Brahim, Mesli, Naima, Kebaili, Sihem, Sidimansour, Noureddine, Benlazar, Mohamed Mohamed, Zouaoui, Zahia, Aberkane, Mohamed, Bachiri, Aissa, Mezhoud, Faiza, Ouarlent, Yamina, Gaid, Hichem, Mehalhal, Nemra, Talbi, Mustapha, Touati, Laid, Lakhdari, Nordine, Bendjaballah, Bassima, Djillali, Malika, Belakehal, Salaheddin, Djouadi, Khadija, Ardjoun, Fatima zohra, Ramaoun, Mohamed, Benyaa, Nesrine, Nekkal, Salim, Oukid, Salima, Mehdid, Farih, Ait Ameur, Nacer, Yachekour, Toufik, Benakli, Malek, Metahri, Noureddine, Bazarbachi, Ali

“…Introduction: Acute myeloid leukaemia (AML) is a group of heterogeneous malignant disorders. AML incidence rates in world populations generally ranged from 3.0…”
Get full text

MPN-076 Impact of Comorbidities and Response to Treatment on the MPN SAF Assessment of Philadelphia Chromosome-Negative Myeloproliferative Syndromes by Ramdoun, Amina, Hadjeb, Asma, Chereti, Malika, Benichou, Soraya, Zouaoui, Zahia, Benlazar, Sidi Mohamed El Amine

“…Philadelphia chromosome-negative myelopro-liferative neoplasms (MPN) are a heterogeneous group of hematological malignancies including essential…”
Get full text

Poster: CML-068 Impact of Low Grade Effects of Tyrosine Kinase Inhibitors on the Quality of Life of Patients Treated for Chronic Myeloid Leukemia by Benlazar, Sidi Mohamed El Amine, Hadjeb, Asma, Zemri, Naima, Ouadah, Fouzia, Siali, Najet, Zouaoui, Zahia

Get full text

Poster: MPN-076 Impact of Comorbidities and Response to Treatment on the MPN SAF Assessment of Philadelphia Chromosome–Negative Myeloproliferative Syndromes by Ramdoun, Amina, Hadjeb, Asma, Chereti, Malika, Benichou, Soraya, Zouaoui, Zahia, Benlazar, Sidi Mohamed El Amine

Get full text

CML-068 Impact of Low Grade Effects of Tyrosine Kinase Inhibitors on the Quality of Life of Patients Treated for Chronic Myeloid Leukemia by Benlazar, Sidi Mohamed El Amine, Hadjeb, Asma, Zemri, Naima, Ouadah, Fouzia, Siali, Najet, Zouaoui, Zahia

Get full text